A new high-Sensitive nephelometric method for assaying serum C-Reactive protein based on phosphocholine interaction

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 6, 2014, Pages 861-867

  Drieghe, Stefanie A ^a   Alsaadi, Hani ^a   Tugirimana, Pierrot L ^a   Delanghe, Joris R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

C reactive protein; Nephelometric assay; Phosphocholine

Indexed keywords

BUFFER; C REACTIVE PROTEIN; INTRALIPID; PHOSPHORYLCHOLINE; SOYBEAN OIL; TRIS CALCIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CHEMISTRY; CALIBRATION; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DILUTION; HUMAN; IMMUNE FUNCTION TEST; IMMUNOTURBIDIMETRY; INCUBATION TIME; LIMIT OF DETECTION; NEPHELOMETRY; PH; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; SENSITIVITY AND SPECIFICITY; SERUM; TURBIDIMETRY; BLOOD ANALYSIS; CHEMISTRY; PHOTOMETRY; PROCEDURES;

BLOOD CHEMICAL ANALYSIS; C-REACTIVE PROTEIN; CALIBRATION; HUMANS; LIMIT OF DETECTION; NEPHELOMETRY AND TURBIDIMETRY; PHOSPHORYLCHOLINE;

EID: 84903607407     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0669     Document Type: Article

References (30)

1. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol 2001;38:189-97 (Pubitemid 32786776)
2. Ablij HC, Meinders AE. C-reactive protein: history and revival. Eur J Intern Med 2002;13:412-22
3. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann NY Acad Sci 1982;389:406-18 (Pubitemid 12013205)
4. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology 1991;23:118-24
5. Ridker PM, Rifai N. C-reactive protein and cardiovascular disease. St-Laurent, Canada: MediEdition Inc., 2006:393
6. Pena JM, MacFadyen J, Glynn RJ, Ridker PM. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trail. Eur Heart J 2012;33:531-37
7. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207
8. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon III RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511 (Pubitemid 36158056)
9. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2010;122:e584-636
10. Algarra M, Gomes D, Esteves da Silva JC. Current analytical strategies for C-reactive protein quantification in blood. Clin Chim Acta 2012;415:1-9
11. Deegan O, Walshe K, Kavanagh K, Doyle S. Quantitative detection of C-reactive protein using phosphocholine labelled enzyme or microspheres. Anal Biochem 2003;312:175-81 (Pubitemid 36151129)
12. Heegaard PM, Pedersen HG, Jensen AL, Boas U. A robust quantitative solid phase immunoassay for the acute phase protein C-reactive protein (CRP) based on cytidine 59-diphosphocholine coupled dendrimers. J Immunol Methods 2009;343:112-8
13. Kint JA. A nephelometric assay of CRP with Intralipid as reagent. Clin Chem 2001;47(Suppl):A26 [abstract]
14. Rowe IR, Soutar AK, Pepys MB. Agglutination of intravenous lipid emulsion ('Intralipid') and plasma lipoproteins by C-reactive protein. Clin Exp Immunol 1986;66:241-7 (Pubitemid 16020162)
15. Tuckwell KR. Intralipid. Pharmacia and UpJohn product information. MIMS Annual 1997;19:1110-1
16. Nesheim M, Samis J, Walker J, Becker L, Brufatto N, Fischer T, et al. Lipoprotein-complexed C-reactive protein and the biphasic transmittance waveform in critically ill patients. Blood Rev 2002;16:S15-22
17. Rowe IF, Soutar AK, Trayner IM, Thompson GR, Pepys MB. Circulating human C-reactive protein binds very low-density lipoproteins. Clin Exp Immunol 1984;58:237-44 (Pubitemid 14029148)
18. Tugirimana PL, Holderbeke AL, Kint JA, Delanghe Jr. A new turbidimetric method for assaying serum C-reactive protein based on phosphocholine interaction. Clin Chem Lab Med 2009;47:1417-22
19. Tuengler P, Metzmann E, Pauly HE, Becker W. New immunodiagnostic systems. Behring Inst Mitt 1988;82:282-308 (Pubitemid 19226381)
20. Konsensuswerte der Deutschen Gesellschaft für Laboratoriumsmedizin der Deutschen Gesellschaft für Klinische Chemie und des Verbandes der Diagnostica- Industrie e.V. (VDGH). Clin Lab 1995;41:743-8
21. Fink PC, Römer M, Haeckel R, Fateh-Moghadam A, Delanghe J, Gressner AM, et al. Measurement of proteins with the Behring Nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem 1989;27:261-76 (Pubitemid 19110744)
22. Whicher JT, Ritchie RF, Johnson AM, Baudner S, Bienvenu J, Blirup-Jensen S, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934-8 (Pubitemid 24166313)
23. Volanakis JE, Lowell Clements W, Schrohenloher RE. C-reactive protein: purification by affinity chromatography and physicochemical characterization. J Immunol Meth 1978;23:285-95 (Pubitemid 9041891)
24. Westgard QC. Method validation - the detection limit experiment. Available from: http://www.westgard.com/ lesson29.htm. Accessed June, 2013
25. Tugirimana PL, De Clercq D, Holderbeke AL, Kint JA, De Cooman L, Deprez P, et al. A funtional turbidimetric method to determine C-reactive protein in horses. J Vet Diagn Invest 2011;23:308-11
26. Mikolajek H, Kolstoe SE, Pye VE, Mangione P, Pepys MB, Wood SP. Structural basis of ligand specificity in human pentraxins, C-reactive protein and serum amyloid P component. J Mol Recognit 2011;24:371-7
27. Dominici R, Luraschi P, Franzini C. Measurement of C-reactive protein: two high sensitivity methods compared. J Clin Lab Anal 2008;18:280-4
28. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500 (Pubitemid 30056739)
29. Westgard QC. Desirable specifications for total error, imprecision, and bias, derived from intra- and inter-individual biologic variation. Update 2012. Available from: http://www.westgard.com/biodatabase1.htm. Accessed June, 2013
30. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. J Am Med Assoc 2009; 302:37-48.